The methylation of O6-methylguanine methyltransferase (MGMT) is a repair protein that can induce chemotherapy resistance by repairing DNA damage caused by TMZ, and MGMT promoter methylation can inhibit MGMT protein expression and enhance the sensitivity of glioma patients to TMZ treatment [25]. Here, MGMT is linked to glioma.